-
Real Time Chart
-
Stock Profile
-
Stock Fundamentals
Financials As Reported
-
accession Number
0000313143-23-000014
-
accounts Payable Current
63,929,000
-
accounts Receivable Net Current
179,142,000
-
accumulated Depreciation Depletion And Amortization Property Plant And Equipment
633,330,000
-
accumulated Other Comprehensive Income Loss Net Of Tax
--30,381,000
-
allocated Share Based Compensation Expense
25,583,000
-
amendment Flag
false
-
assets
1,934,825,000
-
assets Current
769,722,000
-
auditor Firm Id
42
-
auditor Location
Boston, Massachusetts
-
auditor Name
Ernst & Young LLP
-
cash And Cash Equivalents At Carrying Value
284,466,000
-
cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
284,466,000
-
cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
24,970,000
-
cik
313,143
-
city Area Code
(781)
-
common Stock Par Or Stated Value Per Share
0.01
-
common Stock Shares Authorized
150,000,000
-
common Stock Shares Issued
50,448,519
-
common Stock Shares Outstanding
50,448,519
-
comprehensive Income Net Of Tax
110,974,000
-
contract With Customer Liability
30,200,000
-
contract With Customer Liability Current
30,209,000
-
contract With Customer Liability Revenue Recognized
24,300,000
-
cost Of Goods And Services Sold
553,563,000
-
current Federal Tax Expense Benefit
6,461,000
-
current Fiscal Year End Date
--04-01
-
current Foreign Tax Expense Benefit
8,940,000
-
current State And Local Tax Expense Benefit
4,824,000
-
date Filed
2023-05-22
-
deferred Federal Income Tax Expense Benefit
14,298,000
-
deferred Foreign Income Tax Expense Benefit
--843,000
-
deferred Income Tax Expense Benefit
5,777,000
-
deferred Income Tax Liabilities
112,477,000
-
deferred State And Local Income Tax Expense Benefit
--7,678,000
-
deferred Tax Assets Gross
90,361,000
-
deferred Tax Assets Liabilities Net
81,523,000
-
deferred Tax Assets Tax Credit Carryforwards
5,072,000
-
deferred Tax Assets Tax Deferred Expense Reserves And Accruals
15,680,000
-
deferred Tax Assets Valuation Allowance
8,838,000
-
deferred Tax Liabilities Other
2,942,000
-
depreciation
51,200,000
-
document Annual Report
true
-
document Fiscal Period Focus
FY
-
document Fiscal Year Focus
2,023
-
document Period End Date
2023-04-01
-
document Transition Report
false
-
document Type
10-K
-
earnings Per Share Basic
2.27
-
earnings Per Share Diluted
2.24
-
effective Income Tax Rate Continuing Operations
0.184
-
effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
0.21
-
entity Address Address Line 1
125 Summer Street,
-
entity Address City Or Town
Boston,
-
entity Address Postal Zip Code
2,110
-
entity Address State Or Province
MA
-
entity Central Index Key
313,143
-
entity Current Reporting Status
Yes
-
entity Emerging Growth Company
false
-
entity File Number
001-14041
-
entity Filer Category
Large Accelerated Filer
-
entity Incorporation State Country Code
MA
-
entity Interactive Data Current
Yes
-
entity Name
HAEMONETICS CORP
-
entity Registrant Name
HAEMONETICS CORPORATION
-
entity Shell Company
false
-
entity Small Business
false
-
entity Tax Identification Number
04-2882273
-
entity Voluntary Filers
No
-
entity Well Known Seasoned Issuer
Yes
-
gross Profit
615,097,000
-
icfr Auditor Attestation Flag
true
-
income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
141,403,000
-
income Loss From Continuing Operations Before Income Taxes Foreign
55,746,000
-
income Tax Expense Benefit
26,000,000
-
income Tax Reconciliation Foreign Income Tax Rate Differential
--2,408,000
-
income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
29,695,000
-
income Tax Reconciliation State And Local Income Taxes
2,939,000
-
income Tax Reconciliation Tax Credits Research
2,073,000
-
increase Decrease In Accounts Receivable
24,421,000
-
increase Decrease In Inventories
--30,754,000
-
interest Paid Net
13,587,000
-
inventory Net
259,379,000
-
irs Number
42,882,273
-
lessee Operating Lease Liability Payments Due
77,630,000
-
lessee Operating Lease Liability Payments Due After Year Five
33,646,000
-
lessee Operating Lease Liability Payments Due Next Twelve Months
9,813,000
-
lessee Operating Lease Liability Payments Due Year Five
7,490,000
-
lessee Operating Lease Liability Payments Due Year Four
9,073,000
-
lessee Operating Lease Liability Payments Due Year Three
8,601,000
-
lessee Operating Lease Liability Payments Due Year Two
9,007,000
-
lessee Operating Lease Liability Undiscounted Excess Amount
14,565,000
-
liabilities And Stockholders Equity
1,934,825,000
-
liabilities Current
251,816,000
-
local Phone Number
848-7100
-
long Term Debt Current
11,784,000
-
long Term Debt Maturities Repayments Of Principal In Next Twelve Months
12,276,000
-
long Term Debt Maturities Repayments Of Principal In Year Five
0
-
long Term Debt Maturities Repayments Of Principal In Year Four
0
-
long Term Debt Maturities Repayments Of Principal In Year Three
752,000,000
-
long Term Debt Maturities Repayments Of Principal In Year Two
10,500,000
-
long Term Debt Noncurrent
754,102,000
-
net Cash Provided By Used In Financing Activities
--100,364,000
-
net Cash Provided By Used In Investing Activities
--143,788,000
-
net Cash Provided By Used In Operating Activities
273,058,000
-
net Income Loss
115,401,000
-
noncurrent Assets
310,885,000
-
operating Expenses
459,064,000
-
operating Income Loss
156,033,000
-
operating Lease Cost
10,600,000
-
operating Lease Liability
63,065,000
-
operating Lease Liability Current
7,162,000
-
operating Lease Liability Current Statement Of Financial Position Extensible List
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
-
operating Lease Liability Noncurrent
55,903,000
-
operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
-
operating Lease Payments
11,450,000
-
operating Lease Right Of Use Asset
53,413,000
-
operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
-
other Assets Noncurrent
106,975,000
-
other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
--6,016,000
-
other Liabilities Current
111,628,000
-
other Liabilities Noncurrent
74,715,000
-
other Nonoperating Income Expense
--14,630,000
-
payments For Repurchase Of Common Stock
75,000,000
-
payments To Acquire Businesses Net Of Cash Acquired
2,850,000
-
payments To Acquire Property Plant And Equipment
110,191,000
-
period End
1,680,307,200,000
-
period Start
1,648,944,000,000
-
proceeds From Payments For Other Financing Activities
--44,000
-
property Plant And Equipment Gross
944,215,000
-
property Plant And Equipment Net
310,885,000
-
repayments Of Long Term Debt
9,625,000
-
report Link
https://www.sec.gov/Archives/edgar/data/313143/000031314323000014/hae-20230401_htm.xml
-
research And Development Expense
50,131,000
-
retained Earnings Accumulated Deficit
253,168,000
-
selling General And Administrative Expense
376,675,000
-
share Based Compensation
25,583,000
-
stockholders Equity
817,997,000
-
trading Symbol
HAE
-
unrecognized Tax Benefits
3,941,000
-
unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
0
-
unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
292,000
-
unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
0
-
unrecognized Tax Benefits That Would Impact Effective Tax Rate
3,200,000
-
update
1970-01-01
-
weighted Average Number Diluted Shares Outstanding Adjustment
637,000
-
weighted Average Number Of Diluted Shares Outstanding
51,420,000
-
weighted Average Number Of Shares Outstanding Basic
50,783,000
-
id
REPORTED_FINANCIALS
-
key
HAE
-
subkey
10-K
-
date
2023-05-22
-
updated
2023-05-23
-
Symbol Info
-
Symbol Over View
-
Technical Analysis
HAE stock fundamentals - financials as reported